Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
COPENHAGEN, Denmark, March 12, 2026 (GLOBE NEWSWIRE) -- Cbio A/S today announced that it has received regulatory clearance to begin a first-in-human Phase I/IIa clinical trial of novoleucel, the ...
Millions of neurons branch throughout our bodies, keeping them in close communication with our brains. This peripheral ...